Documents
Application Sponsors
ANDA 076642 | AMNEAL PHARMS NY | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | TABLET;ORAL | 7.5MG;200MG | 0 | HYDROCODONE BITARTRATE AND IBUPROFEN | HYDROCODONE BITARTRATE; IBUPROFEN |
002 | TABLET;ORAL | 5MG;200MG | 0 | HYDROCODONE BITARTRATE AND IBUPROFEN | HYDROCODONE BITARTRATE; IBUPROFEN |
003 | TABLET;ORAL | 2.5MG;200MG | 0 | REPREXAIN | HYDROCODONE BITARTRATE; IBUPROFEN |
004 | TABLET;ORAL | 10MG;200MG | 0 | REPREXAIN | HYDROCODONE BITARTRATE; IBUPROFEN |
FDA Submissions
| ORIG | 1 | AP | 2004-03-18 | |
LABELING; Labeling | SUPPL | 2 | AP | 2004-06-16 | |
S; Supplement | SUPPL | 3 | AP | 2004-10-12 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 2007-10-19 | |
LABELING; Labeling | SUPPL | 6 | AP | 2007-10-19 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 2007-10-19 | |
LABELING; Labeling | SUPPL | 8 | AP | 2007-10-19 | |
LABELING; Labeling | SUPPL | 9 | AP | 2007-01-03 | |
LABELING; Labeling | SUPPL | 10 | AP | 2007-01-04 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 2008-03-20 | |
LABELING; Labeling | SUPPL | 20 | AP | 2018-08-15 | STANDARD |
LABELING; Labeling | SUPPL | 22 | AP | 2018-08-15 | STANDARD |
LABELING; Labeling | SUPPL | 23 | AP | 2018-08-15 | STANDARD |
LABELING; Labeling | SUPPL | 24 | AP | 2018-09-21 | STANDARD |
REMS; REMS | SUPPL | 25 | AP | 2018-09-18 | |
LABELING; Labeling | SUPPL | 27 | AP | 2019-07-22 | STANDARD |
LABELING; Labeling | SUPPL | 28 | AP | 2019-10-10 | STANDARD |
LABELING; Labeling | SUPPL | 30 | AP | 2021-03-04 | STANDARD |
LABELING; Labeling | SUPPL | 32 | AP | 2021-04-28 | STANDARD |
Submissions Property Types
SUPPL | 3 | Null | 0 |
SUPPL | 5 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 11 | Null | 0 |
SUPPL | 20 | Null | 7 |
SUPPL | 22 | Null | 7 |
SUPPL | 23 | Null | 7 |
SUPPL | 24 | Null | 15 |
SUPPL | 25 | Null | 15 |
SUPPL | 27 | Null | 15 |
SUPPL | 28 | Null | 15 |
SUPPL | 30 | Null | 15 |
SUPPL | 32 | Null | 15 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
AMNEAL PHARMS NY
cder:Array
(
[0] => Array
(
[ApplNo] => 76642
[companyName] => AMNEAL PHARMS NY
[docInserts] => ["",""]
[products] => [{"drugName":"HYDROCODONE BITARTRATE AND IBUPROFEN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"7.5MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"},{"drugName":"HYDROCODONE BITARTRATE AND IBUPROFEN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"5MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"REPREXAIN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"2.5MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"REPREXAIN","activeIngredients":"HYDROCODONE BITARTRATE; IBUPROFEN","strength":"10MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"HYDROCODONE BITARTRATE AND IBUPROFEN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"7.5MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"HYDROCODONE BITARTRATE AND IBUPROFEN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"5MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"REPREXAIN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"2.5MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"REPREXAIN","submission":"HYDROCODONE BITARTRATE; IBUPROFEN","actionType":"10MG;200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)